Inside Netflix’s Approach To Book Adaptations As ‘Ransom Canyon’ & ‘Forever’ Showrunners Tease Second Seasons

In an exclusive for Deadline, Netflix auspices talked book adaptations like 'Forever' and 'Ransom Canyon' as well as ...

ASH 2025 | Updated Data for Ascentage Pharma‘s Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment

Molecular responses continue to deepen with extended treatment duration, reaching 60% major molecular response at 21 cycles ...

ASH 2025 | Ascentage Pharma Presents Four-Year Follow-Up Data from Registrational Phase II Study of Olverembatinib, Reaffirming Differentiated Long-Term Efficacy an…

Dramatically improved disease control with 21.2 months vs. 2.9 months median event-free survival (EFS) Favorablesafety ...